Insmed Inc Stock Performance

INSM Stock  USD 23.78  0.16  0.67%   
Insmed has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.4433, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Insmed returns are expected to increase less than the market. However, during the bear market, the loss on holding Insmed will be expected to be smaller as well. By evaluating Insmed Inc technical indicators, you can presently evaluate if the expected return of 0.16% will be sustainable into the future. Insmed Inc right now retains a risk of 2.88%. Please check out Insmed variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Insmed will be following its current trending patterns.

Insmed Performance

4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Insmed Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Insmed may actually be approaching a critical reversion point that can send shares even higher in December 2023. ...more
Forward Dividend Yield
Last Split Factor
Last Split Date
Insmed A Hidden Gem or Just Modestly Undervalued
Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Myotonic Dystrophy Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 - Benzinga
EPS Estimate
Adult severe asthma registries POR - Dove Medical Press
EPS Reported
Soleno Therapeutics Provides Corporate Update and Reports Third ... -
Unclassified Event
Begin Period Cash Flow716.8 M
Total Cashflows From Investing Activities-34.6 M

Insmed Relative Risk vs. Return Landscape

If you would invest  2,208  in Insmed Inc on August 30, 2023 and sell it today you would earn a total of  170.00  from holding Insmed Inc or generate 7.7% return on investment over 90 days. Insmed Inc is currently generating 0.1568% in daily expected returns and assumes 2.8837% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Insmed, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
Given the investment horizon of 90 days Insmed is expected to generate 3.68 times more return on investment than the market. However, the company is 3.68 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.01 per unit of risk.

Insmed Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Insmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insmed Inc, and traders can use it to determine the average amount a Insmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0544

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsINSM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

  actual daily
75% of assets are more volatile

Expected Return

  actual daily
97% of assets have higher returns

Risk-Adjusted Return

  actual daily
96% of assets perform better
Based on monthly moving average Insmed is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insmed by adding it to a well-diversified portfolio.

Insmed Fundamentals Growth

Insmed Stock prices reflect investors' perceptions of the future prospects and financial health of Insmed, and Insmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insmed Stock performance.

About Insmed Performance

To evaluate Insmed Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Insmed generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Insmed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Insmed Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Insmed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Effect of Exchange Rate Changes on Cash-996 K-1 M
Return on Investment(40.91)(44.14)
Return on Average Assets(0.40)(0.43)
Return on Average Equity(8.67)(8.90)
Return on Invested Capital(0.37)(0.40)
Return on Sales(1.85)(1.99)

Things to note about Insmed Inc performance evaluation

Checking the ongoing alerts about Insmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Insmed Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 245.36 M. Net Loss for the year was (481.53 M) with profit before overhead, payroll, taxes, and interest of 190.23 M.
Insmed Inc currently holds about 554.87 M in cash with (400.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62.
Insmed Inc has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from Soleno Therapeutics Provides Corporate Update and Reports Third ... -
Evaluating Insmed's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Insmed's stock performance include:
  • Analyzing Insmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insmed's stock is overvalued or undervalued compared to its peers.
  • Examining Insmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Insmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insmed's management team can help you assess the company's leadership.
  • Pay attention to analyst opinions and ratings of Insmed's stock. These opinions can provide insight into Insmed's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Insmed's stock performance is not an exact science, and many factors can impact Insmed's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.